Tranexamic acid for hyperpigmentation

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 2 trial. Mid-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 1 Jun 2025: Trial started, NCT07263841
  2. 4 Dec 2025: Trial registered, NCT07263841

The trials

NCT07263841: Comparison of Effectiveness of Tranexamic Acid Mesotherapy Versus Glutathione Mesotherapy in Post Burn Facial Hyperpigmentation

State
Under way
Phase
Phase 2
People
60 planned
Started
1 Jun 2025
Primary completion
26 Dec 2025
Arms
fitzpatrick skin type3,4 patients of post burn facial hyperpigmentation will be included in this arm
Results
None posted
  1. 1 Jun 2025: Trial started
  2. 4 Dec 2025: Trial registered

How the status changed

  1. 19 Nov 2026: First set: Phase 2 trial

About the treatment

Kind of treatment: Drug.

Also known as Cyclo-f, Cyklokapron, Espercil, Femstrual, Haematrix, Lysteda, Rikavarin, TRANEXAMIC ACID 1 G in 10 mL INTRAVENOUS INJECTION, SOLUTION, Transamin, Tranexamic Acid 500 MG, Tranexamic acid tablets.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.